- Home
- FSV vs LEGN Comparison
FSV vs LEGN Comparison
Compare FSV & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSV
- LEGN
- Stock Information
- Founded
- FSV 1988
- LEGN 2014
- Country
- FSV Canada
- LEGN United States
- Employees
- FSV N/A
- LEGN N/A
- Industry
- FSV Real Estate
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- FSV Finance
- LEGN Health Care
- Exchange
- FSV Nasdaq
- LEGN Nasdaq
- Market Cap
- FSV 7.8B
- LEGN 7.0B
- IPO Year
- FSV N/A
- LEGN 2020
- Fundamental
- Price
- FSV $172.36
- LEGN $29.05
- Analyst Decision
- FSV Buy
- LEGN Strong Buy
- Analyst Count
- FSV 5
- LEGN 13
- Target Price
- FSV $203.00
- LEGN $75.67
- AVG Volume (30 Days)
- FSV 95.9K
- LEGN 1.6M
- Earning Date
- FSV 04-24-2025
- LEGN 05-13-2025
- Dividend Yield
- FSV 0.64%
- LEGN N/A
- EPS Growth
- FSV 42.94
- LEGN N/A
- EPS
- FSV 2.88
- LEGN N/A
- Revenue
- FSV $5,309,675,000.00
- LEGN $728,303,000.00
- Revenue This Year
- FSV $7.67
- LEGN $64.21
- Revenue Next Year
- FSV $6.82
- LEGN $53.69
- P/E Ratio
- FSV $59.77
- LEGN N/A
- Revenue Growth
- FSV 18.68
- LEGN 112.46
- 52 Week Low
- FSV $141.26
- LEGN $27.34
- 52 Week High
- FSV $197.84
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- FSV 47.88
- LEGN 40.43
- Support Level
- FSV $174.24
- LEGN $28.14
- Resistance Level
- FSV $176.90
- LEGN $31.12
- Average True Range (ATR)
- FSV 2.77
- LEGN 1.87
- MACD
- FSV -0.32
- LEGN -0.22
- Stochastic Oscillator
- FSV 20.32
- LEGN 27.32
About FSV FirstService Corporation
FirstService Corp operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high-, medium-, and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertPro Painters; Pillar to Post; Floor Coverings International; College Pro Painters; and Service America. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.